Health-Related Lifestyle Factors, Sex, and Neural Mechanosensitivity in University Students

March 30, 2026 updated by: Sümeyye Akçay, Fenerbahce University

The Effects of Health-Related Lifestyle Factors and Sex on Neural Mechanosensitivity in University Students

This observational cross-sectional study aims to investigate the effects of health-related lifestyle factors and sex on neural mechanosensitivity in university students. Specifically, the study will examine whether alcohol consumption, smoking status, physical activity level, age, body mass index, and sex are associated with pressure pain thresholds of the tibial and peroneal nerves.

Participants will be university students aged 18 to 30 years enrolled at Fenerbahçe University who voluntarily agree to participate and provide informed consent. Students with neurological disorders, lower extremity musculoskeletal injury or surgery, acute pain, systemic conditions affecting nerve sensitivity, skin problems at the measurement sites, or use of medications that may influence the measurements will be excluded.

Data will be collected face to face. Participants will complete a personal information form including demographic characteristics and lifestyle-related factors. Neural mechanosensitivity will be assessed by measuring pressure pain threshold over the tibial and peroneal nerve regions using a digital algometer. Three measurements will be obtained at each site and the average value will be used for analysis.

The study is expected to improve understanding of factors associated with peripheral nerve mechanosensitivity in young adults and may provide a scientific basis for future clinical and epidemiological research.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

This is an observational, analytical, cross-sectional study designed to evaluate neural mechanosensitivity in healthy university students and to explore its association with health-related lifestyle factors and sex. The main objective is to determine whether alcohol consumption, smoking status, physical activity level, sex, age, and body mass index are associated with pressure pain threshold values measured over the tibial and peroneal nerves.

The study population will consist of students enrolled at Fenerbahçe University. Participants must be between 18 and 30 years of age, willing to participate voluntarily, and able to provide written informed consent. Individuals will be excluded if they have a diagnosed neurological disease, lower extremity musculoskeletal injury or previous surgery, acute pain, diabetes, peripheral neuropathy, systemic disorders that may affect nerve sensitivity, skin lesions or infection at the test site, or use of analgesic or neurologically active medication that could influence the measurements.

Data will be collected in person. After informed consent is obtained, participants will complete a personal information form developed by the investigators. This form will record sociodemographic characteristics and lifestyle-related variables, including age, sex, height, weight, alcohol consumption, smoking status, and physical activity habits. Body mass index will be calculated from height and weight data.

Neural mechanosensitivity will be assessed by pressure pain threshold measurements using a digital algometer. Measurements will be performed over standardized anatomical points corresponding to the tibial nerve and the common peroneal nerve. Pressure will be increased gradually at an approximate rate of 0.5 to 1 kg/cm²/s, and participants will be instructed to indicate when the sensation first becomes painful. Three repeated measurements will be obtained at each site, and the mean value will be used in the analyses. The algometer will be checked according to the manufacturer's calibration standards.

The planned minimum sample size is 55 participants, based on an a priori power analysis performed with G*Power 3.1, assuming an alpha of 0.05, a statistical power of 0.80, and a medium effect size. Statistical analyses will be conducted using IBM SPSS Statistics version 22. Descriptive statistics will summarize participant characteristics. Normality will be assessed using the Shapiro-Wilk test and visual methods. Group comparisons for lifestyle-related factors will be performed using one-way ANOVA, sex differences will be examined using the independent samples t-test, associations with age and body mass index will be tested using Pearson correlation analysis, and linear regression analysis will be used to further evaluate the effect of sex on pressure pain threshold values. Statistical significance will be set at p < 0.05.

This study is expected to provide information about factors associated with peripheral nerve mechanosensitivity in young adults and may contribute to future clinical and epidemiological research in physiotherapy and rehabilitation.

Study Type

Observational

Enrollment (Estimated)

55

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Ataşehir
      • Istanbul, Ataşehir, Turkey (Türkiye), 34758
        • Fenerbahçe University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy university students aged 18 to 30 years enrolled at Fenerbahçe University will be recruited for this observational cross-sectional study. Participants must volunteer to participate, provide written informed consent, and have no condition preventing pressure pain threshold assessment in the tibial and peroneal nerve regions. Students with neurological disease, lower extremity musculoskeletal injury or surgery, acute pain, systemic conditions affecting nerve sensitivity, skin problems at the measurement site, or use of medications that may influence measurements will be excluded.

Description

Inclusion Criteria:

  • Students enrolled at Fenerbahçe University
  • Aged 18 to 30 years
  • Willing to participate voluntarily
  • Able to provide written informed consent
  • No health problem preventing measurement in the tibial and peroneal nerve regions

Exclusion Criteria:

  • Diagnosed neurological disease
  • Lower extremity musculoskeletal injury, previous surgery, or acute pain
  • Diabetes, peripheral neuropathy, or other systemic disease that may affect nerve sensitivity
  • Open wound, infection, or skin problem at the measurement site
  • Use of analgesic or neurologically active medication that may affect the measurements

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy University Students
University students aged 18 to 30 years enrolled at Fenerbahçe University who voluntarily participate in the study and undergo assessment of lifestyle factors and neural mechanosensitivity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure Pain Threshold of the Tibial Nerve
Time Frame: At baseline (single assessment)
Pressure pain threshold measured over the tibial nerve region using a digital algometer. Three measurements will be obtained and the mean value will be used for analysis.
At baseline (single assessment)
Pressure Pain Threshold of the Common Peroneal Nerve
Time Frame: At baseline (single assessment)
Pressure pain threshold measured over the common peroneal nerve region using a digital algometer. Three measurements will be obtained and the mean value will be used for analysis.
At baseline (single assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fenerbahce University

Investigators

  • Principal Investigator: Sümeyye Akçay, Fenerbahçe University
  • Study Chair: Duygu Aktar Reyhanioğlu, Asst. Prof., Fenerbahçe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

March 30, 2026

First Submitted That Met QC Criteria

March 30, 2026

First Posted (Actual)

April 6, 2026

Study Record Updates

Last Update Posted (Actual)

April 6, 2026

Last Update Submitted That Met QC Criteria

March 30, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FenerbahceUniv

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual participant data will be shared. The study involves a relatively small single-center sample of university students, and data sharing could increase the risk of participant re-identification. Results will be reported in aggregate form only, in accordance with ethical approval, informed consent, and applicable data protection regulations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on University Students

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe